Angiogenesis

, Volume 19, Issue 3, pp 297–309

EphrinB2/EphB4 pathway in postnatal angiogenesis: a potential therapeutic target for ischemic cardiovascular disease

  • Du Yang
  • Chunna Jin
  • Hong Ma
  • Mingyuan Huang
  • Guo-Ping Shi
  • Jianan Wang
  • Meixiang Xiang
Review Paper

DOI: 10.1007/s10456-016-9514-9

Cite this article as:
Yang, D., Jin, C., Ma, H. et al. Angiogenesis (2016) 19: 297. doi:10.1007/s10456-016-9514-9

Abstract

Ischemic cardiovascular disease remains one of the leading causes of morbidity and mortality in the world. Proangiogenic therapy appears to be a promising and feasible strategy for the patients with ischemic cardiovascular disease, but the results of preclinical and clinical trials are limited due to the complicated mechanisms of angiogenesis. Facilitating the formation of functional vessels is important in rescuing the ischemic cardiomyocytes. EphrinB2/EphB4, a novel pathway in angiogenesis, plays a critical role in both microvascular growth and neovascular maturation. Hence, investigating the mechanisms of EphrinB2/EphB4 pathway in angiogenesis may contribute to the development of novel therapeutics for ischemic cardiovascular disease. Previous reviews mainly focused on the role of EphrinB2/EphB4 pathway in embryo vascular development, but their role in postnatal angiogenesis in ischemic heart disease has not been fully illustrated. Here, we summarized the current knowledge of EphrinB2/EphB4 in angiogenesis and their interaction with other angiogenic pathways in ischemic cardiovascular disease.

Keywords

Ischemic cardiovascular diseaseEphrinB2/EphB4 pathwayAngiogenesisVessel maturationVEGF-Dll4/Notch-EphrinB2 cascade

Copyright information

© Springer Science+Business Media Dordrecht 2016

Authors and Affiliations

  • Du Yang
    • 1
  • Chunna Jin
    • 1
  • Hong Ma
    • 1
  • Mingyuan Huang
    • 1
  • Guo-Ping Shi
    • 2
  • Jianan Wang
    • 1
  • Meixiang Xiang
    • 1
  1. 1.Department of Cardiology, Cardiovascular Key Laboratory of Zhejiang Province, The Second Affiliated HospitalZhejiang University School of MedicineHangzhouChina
  2. 2.Department of Cardiovascular MedicineBrigham and Women’s Hospital and Harvard Medical SchoolBostonUSA